Navigation Links
Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
Date:5/24/2011

May 25-28; London, United Kingdom.
  • Schlesinger N, Alten R, Bardin T, et al. Efficacy of canakinumab versus triamcinolone acetonide in acute gouty arthritis patients: results of the Beta-RELIEVED II study (REsponse in acute fLare and In prEVEntion of episoDes of re-flare in gout).  Poster (THU0019) presented at: The 2011 Annual European Congress of The European League Against Rheumatism; 2011 May 25-28; London, United Kingdom.
  • Schlesinger N, Alten R, Bardin T, et al. Efficacy of canakinumab vs triamcinolone acetonide in preventing recurrent flares in acute gouty arthritis patients contraindicated, intolerated or unresponsive to NSAIDs and/or colchicine. Abstract (EULAR11-2018 for OP0107) at: The 2011 Annual European Congress of The European League Against Rheumatism; 2011 May 25-28; London, United Kingdom.
  • ILARIS [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2009.

  • Novartis Media RelationsTina TuttleNovartis US Pharma Communications

    +1 862 778 1625 (direct)

    +1 862 222 6092 (mobile)

    tina.tuttle@novartis.com

    Michael BillingsNovartis US Pharma Communications

    +1 862 778 86565 (direct)

    +1 201 400 1854 (mobile)

    michael.billings@novartis.comAnna FrableNovartis US Pharma Communications

    +1 862 778 5388 (direct)

    +1 732 673 5262 (mobile)

    anna.frable@novartis.come-mail: media.relations@novartis.com

    Novartis Investor RelationsCentral phone:+41 61 324 7944Susanne Schaffert

    +41 61 324 7944

    North America:Pierre-Michel Bringer

    +41 61 324 1065

    Richard Jarvis

    +1 212 830 2433Thomas Hungerbuehler

    +41 61 324 8425

    Jill Pozarek

    +1 212 830 2445Isabella Zinck

    +41 61 324 7188

    Edwin Valeriano

    +1 212 830 2456e-mail
    '/>"/>

    SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
    3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
    4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
    5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
    6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
    7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
    8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
    9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
    10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
    11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... , Aug. 31, 2015  Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today it has completed enrollment of ... Review Committee (DRC) earlier this year, into the ... a first-in-class innate defense regulator (IDR) and is ...
    (Date:8/31/2015)... Aug. 31, 2015  QT Vascular Ltd., together with its ... with its subsidiaries, the "Group"), a global company ... advanced therapeutic solutions for the minimally invasive treatment ... of the below-the-knee ("BTK") cohort of patients in ... presented on August 15, 2015 at the 5th ...
    (Date:8/30/2015)... y LONDRES, August 30, 2015 ... holística de l cuidado al paciente ... trayecto   Royal Philips  ... europeo de IntelliSpace Cardiovascular , un sistema web ... herramientas para acceder, analizar y compartir imágenes cardiovasculares e ...
    Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
    ... Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery and life sciences ... Austria AG for the co-development and manufacture of ... The agreement combines Sony DADC,s premier Blu-ray Disc™ ...
    ... Nov. 3, 2010 Cyberonics, Inc. (Nasdaq: CYBX ) ... second quarter ended October 29, 2010 of its fiscal year ending ... ET.  The company will conduct a conference call to discuss those ... Fiscal Year 2011 Second Quarter Results Conference Call InstructionsTo ...
    Cached Medicine Technology:Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results 2
    (Date:9/1/2015)... ... September 01, 2015 , ... ... has established the MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It ... rapidly-growing alliance is dedicated to the provision of quality addiction treatment and ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Elizabeth Callahan, MD, founder and ... first in the area to offer RADIESSE® filler treatment for volume loss in the ... of tendons and veins in the hands, delivering smooth, natural-looking results that can last ...
    (Date:9/1/2015)... IL (PRWEB) , ... September 01, 2015 , ... ... and Zeel™, has recently sponsored an educational workshop for physician assistants (PAs) practicing ... Injections of Traumeel™ and Zeel™” was held by Dr. Erick Salado, an orthopedic ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Curly Hair ... hair salons. This highly anticipated partnership between Curly Hair Solutions™ and Trade Secrets ... Founder Jonathan Torch and the Curly Hair Solutions™ team could not be more ...
    (Date:8/31/2015)... ... August 31, 2015 , ... ... released their latest predictive use case focused on helping hospital perform under the ... this program, hospital payments are adjusted based on performance across four domains related ...
    Breaking Medicine News(10 mins):Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2
    ... , HOFFMAN ESTATES, Ill., July 16 ... America,s top medical institutions in the annual America,s Best Hospitals list published ... magazine. St. Alexius Medical Center was ranked among the top 50 hospitals ... , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090716/CG47487 ) ...
    ... NATICK, Mass., July 16 Boston Scientific Corporation (NYSE: ... from the U.S. Food and Drug Administration (FDA) to market ... drug-eluting stent (DES) designed for long lesions. At 38 ... option that can potentially reduce the number of stents used ...
    ... , PEKIN, Ill., July 16 ... of prescription foot and ankle orthoses and accompanying high technology ... award, which is given annually by the national Department of ... employment opportunities and support to veterans. , ...
    ... WALTHAM, Mass., July 16 According to Millennium ... intelligence, the fat reduction device market will experience the highest ... MRG,s European Markets for Body Contouring Devices 2009 ... fueled by physician adoption of newer modalities like transdermal ultrasound ...
    ... , , FRANKLIN, Mass., ... a company focused on innovative cardiac and vascular medical device-based ... Cardiac Angiography in Renally Impaired Patients (CARE) Study determined that ... from pulmonary edema to death, and that patients with CIN ...
    ... , , , BEIJING, July ... access to fast and efficient radiotherapy treatments with the introduction of ... ) at the Beijing Cancer Hospital. BCH is the first ... more advanced care to a greater number of patients. , ...
    Cached Medicine News:Health News:St. Alexius Medical Center Named to America's Best Hospitals Rankings 2Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 2Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 3Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 4Health News:PAL Health Technologies Wins State-Level Prestigious 'Employer of the Year' Award 2Health News:Fat Reduction Market in Europe to Soar Despite Economic Downturn 2Health News:PLC Medical Systems Announces Publication of Care Study Update 2Health News:PLC Medical Systems Announces Publication of Care Study Update 3Health News:Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 2Health News:Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 3
    The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
    The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
    This instrument can be used as a spoon forceps in gynecologic surgery....
    This is a single-action instrument that features a spring handle....
    Medicine Products: